Dimerizer-mediated regulation of gene expression

Cold Spring Harbor Protocols

Volumn 7, Issue 7, 2012, Pages 767-770

  Rivera, Victor M ^a   Berk, Lori ^a   Clackson, Tim ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AP 21967; AP 23102; CYTOPLASM PROTEIN; DIMER; DNA BINDING PROTEIN; FK 506 BINDING PROTEIN; HUMAN GROWTH HORMONE; INTERLEUKIN 2; OCTAMER TRANSCRIPTION FACTOR 1; RAPAMYCIN; RAPAMYCIN DERIVATIVE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; DRUG DERIVATIVE; HYBRID PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; DIMERIZATION; DNA BINDING MOTIF; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; NONHUMAN; TRANSCRIPTION INITIATION; CYTOMEGALOVIRUS; DRUG EFFECT; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR BIOLOGY; PROMOTER REGION; SIMIAN VIRUS 40;

CYTOMEGALOVIRUS; SIMIAN VIRUS 40;

CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HUMANS; MOLECULAR BIOLOGY; PROMOTER REGIONS, GENETIC; RECOMBINANT FUSION PROTEINS; SIMIAN VIRUS 40; SIROLIMUS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84864445494     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.top070128     Document Type: Article

References (16)

1. Chen J, Zheng XF, Brown EJ, Schreiber SL. 1995. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. Proc Natl Acad Sci 92: 4947-4951.
2. Choi J, Chen J, Schreiber SL, Clardy J. 1996. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science 273: 239-242.
3. Clackson T. 2000. Regulated gene expression systems. 2000. Gene Ther 7: 120-125.
4. Ho SN, Biggar SR, Spencer DM, Schreiber SL, Crabtree GR. 1996. Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature 382: 822-826.
5. Magari SR, Rivera VM, Iuliucci JD, Gilman M, Cerasoli F Jr. 1997. Pharmacologic control of a humanized gene therapy system implanted into nude mice. J Clin Invest 100: 2865-2872.
6. Natesan S, Molinari E, Rivera VM, Rickles R, Gilman M. 1999. A general strategy to enhance the potency of chimeric transcription factors. Proc Natl Acad Sci 96: 13898-13903.
7. Pollock R, Clackson T. 2002. Dimerizer-regulated gene expression. Curr Opin Biotechnol 13: 459-467.
8. Pollock R, Issner R, Zoller K, Natesan S, Rivera VM, Clackson T. 2000. Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector. Proc Natl Acad Sci 97: 13221-13226.
9. Pollock R, Giel M, Linher K, Clackson T. 2002. Regulation of endogenous gene expression with a small-molecule dimerizer. Nat Biotechnol 20: 729-733.
10. Pomerantz JL, Sharp PA, Pabo CO. 1995. Structure-based design of transcription factors. Science 267: 93-96.
11. Rivera VM, Clackson T, Natesan S, Pollock R, Amara JF, Keenan T, Magari SR, Phillips T, Courage NL, Cerasoli F Jr, et al. 1996. A humanized system for pharmacologic control of gene expression. Nat Med 2: 1028-1032.
12. Rivera VM, Gao GP, Grant RL, Schnell MA, Zoltick PW, Rozamus LW, Clackson T, Wilson JM. 2005. Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood 105: 1424-1430.
13. Rivera VM, Berk L, Clackson T. 2012a. Dimerizer-mediated regulation of gene expression in vitro. Cold Spring Harb Protoc doi: 10.1101/pdb.prot070136.
14. Rivera VM, Berk L, Clackson T. 2012b. Dimerizer-mediated regulation of gene expression in vivo. Cold Spring Harb Protoc doi: 10.1101/pdb.prot070144.
15. Schmitz ML, Baeuerle PA. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-3BA;B. EMBO J 10: 3805-3817.
16. Spencer DM, Wandless TJ, Schreiber SL, Crabtree GR. 1993. Controlling signal transduction with synthetic ligands. Science 262: 1019-1024.